Continuous Renal Replacement Therapy Market Report Highlights The Competitive Scenario With Impact Of Drivers And Challenges 2026
Renal
replacement is a therapy used to exchange the normal
blood-filtering function of the kidneys. It plays a vital role in
treating severe acute kidney injuries and end-stage kidney diseases.
Renal replacement therapy are of three types, which includes
peritoneal dialysis, intermittent hemodialysis, and continuous renal
replacement therapy.
Continuous renal
replacement therapy is a treatment given to the patients with acute
kidney injury, particularly for hemo-dynamically unstable cases.
Continuous renal replacement therapy involves hemodialysis,
hemofiltration or a combination of both. The continuous renal
replacement therapy differs from the conventional renal replacement
therapies where intermittent hemodialysis lasts for six hours.
However, continuous renal replacement therapy last for 24 hours.
Removal of fluid or solute at the slower rate per unit time is the
major advantage of continuous renal replacement therapy. Therefore,
continuous renal replacement therapy is largely accepted than the
conventional therapies involving intermittent hydrolysis globally.
Rising incidence
of chronic kidney disease to boost the growth of continuous renal
replacement therapy market
The major factors
contributing the growth of continuous renal replacement therapy
market is rising incidence of chronic kidney disease, which is a
major risk factor for diabetes, hypertension, cardiovascular disease,
and inflammatory disease of the kidney called glomerulonephritis.
According to National Center for Biotechnology Information (NCBI) in
2014, around 200 million people were diagnosed with chronic kidney
disease, which may lead to the complete loss of renal failure or
kidney injury and can also result in end stage renal disease if left
untreated. Thereby, requiring continuous renal replacement therapy.
The other factors driving the growth of continuous renal replacement
therapy market are rise in the number of acute kidney injury cases
and other technological advancements in the field of pediatric, such
as Cardio-Renal Pediatric Dialysis Emergency Machine (CARPEDIUM) for
the treatment of acute kidney injury in small infants. However,
reimbursement, procedural costs, and high complexity of continuous
renal replacement therapy, and dearth of trained nurses are the
factors that are restraining the growth of continuous real
replacement therapy market.
Continuous Renal
Replacement Therapy Market Taxonomy
Continuous renal
replacement therapy market can be segmented on the basis of product,
modality, end user, and geography.
On the basis of
product, continuous renal replacement therapy market is segmented
into:
Dialysate And
Replacement Fluids
Disposables
Bloodline Sets
Hemofilters
Systems
On the basis of
modality, continuous renal replacement therapy market is segmented
into:
Slow Continuous
Ultrafiltration
Continuous
Venovenous Hemofiltration
Continuous
Venovenous Hemodialysis
Continuous
Venovenous Hemodiafiltration
On the basis of end
user, continuous replacement therapy market is segmented into:
Hospitals
Dialysis Clinics
Others
On the basis of
region, continuous renal replacement therapy market is segmented into
North America, Latin America, Europe, Asia pacific, Middle East, and
Africa. North America is expected to dominate the global continuous
renal replacement therapy market, owing to the rising incidences of
chronic kidney disease. According to American Kidney Fund, in 2015,
around 31 million people were diagnosed with chronic kidney disease
and it is the ninth leading cause of death in the U.S. Moreover, an
innovative technology called wearable artificial kidney launched in
the U.S, in 2015 has been designed to provide continuous renal
replacement 24 hours a day thus providing feasibility and
affordability to the patients. Furthermore, Asia Pacific is expected
to emerge as the most lucrative market for continuous renal
replacement therapy over the forecast period due to continuous rise
in investments aimed at improving healthcare infrastructure and high
unmet medical needs pertaining to target disease, such as
hypertension and diabetes.
Inquire Here
Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1051
Innovative
Multifiltrate PRO launched by Fresenius Medical care AG &Co. KGaA
to boost the growth of continuous renal replacement therapy market
The key players in
the continuous renal replacement therapy market are Baxter
International, Nikkiso Co. Ltd., B. Braun Melsungen AG, Bellco S.r.I,
NxStage Medical, Asahi Kasei Corporation, Medica S.P.A, Toray Medical
Co., Nipro Corporation, Medtronic Plc, and Dialysis Solutions Inc.
The key players are focusing on strategic mergers and acquisition and
development of innovative therapy systems. For instance, Fresenius
Medical Care AG & Co. KGaA, in May 2015, launched a new therapy
system named Multifiltrate PRO for continuous renal replacement
therapy and also for the acute kidney failure.
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment